Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Normative State and Variation in Growth, Hematology, Hydration, Oxidation, Infection, Inflammation, Guatemalan Children

28 de julho de 2014 atualizado por: María José Soto

Study on the Normative State and Inter- and Intra-individual Variation in Growth, Hematology, Hydration and Markers of Oxidation, Infection and Inflammation in Preschool Children With a Similar Dietary Intake

This study will provide the researchers with an opportunity for the investigation of the biomarkers and different human biology component variable interactions in children; information that can generate new correlations between markers not known at the moment.

Regarding their analysis, variation could have multiple connotations. A categorical that refers to a specific state, established with a diagnostic standard. And a numerical, referring to a range or the absolute value limits in a continuous spectrum; this research will allow us to express variability in the distance amplitude of the obtained values level, as well as classifications or categories previously established in the possible cases.

OBJECTIVES PRINCIPAL OBJECTIVE

To estimate the inter and intra-individual variety in a selected series or biological variables determinant of growth, body composition, infection, oxidation, inflammation and hydration, in preschool children sharing the same institutional-based diet.

SPECIFIC OBJECTIVES

  • To determine the inter and intra-individual variation of growth in preschool children, with a similar diet, who attend Secretariat of Beneficial Works of the First Lady system daycare centers and to compare between semi-urban and rural.
  • To describe the inter-individual variation of the red blood cells circulating mass in preschool children, with a similar diet, who attend day care centers and to compare between semi-urban and rural.
  • To determine the inter-individual variation of systemic and intraintestinal oxidation in preschool children, with a similar diet, who attend daycare centers and to compare between semi-urban and rural.
  • To describe the inter-individual variation of systemic and intraintestinal inflammation in preschool children, with a similar diet, who attend daycare centers and to compare between semi-urban and rural.
  • To determine the inter and/or intra-individual variation of urinary tract infection and gastrointestinal parasite infestation in preschool children, with a similar diet, who attend daycare centers and to compare between semi-urban and rural.
  • To describe the inter and intra-individual variation of the hydration status in preschool children, with a similar diet, who attend daycare centers and to compare between semi-urban and rural.
  • To explore intra-individual associations in variables of the same research component or different component variables.

Visão geral do estudo

Status

Concluído

Condições

Descrição detalhada

Please note protocol is also available in Spanish.

Tipo de estudo

Observacional

Inscrição (Real)

91

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • Quetzaltenango
      • Guatemala, Quetzaltenango, Guatemala, 09001
        • Center for Studies of Sensory Impairment Aging and Metabolism

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

1 ano a 7 anos (Filho)

Aceita Voluntários Saudáveis

Sim

Gêneros Elegíveis para o Estudo

Tudo

Método de amostragem

Amostra Não Probabilística

População do estudo

Apparently healthy children who attend 3 daycare centers (one semi-urban, one urban-marginal and one rural) from the Secretariat of Beneficial Works of the First Lady (SOSEP) system in the Western Highlands in Quetzaltenango, Guatemala.

Descrição

Inclusion Criteria:

  • To be attending one of the SOSEP systems assigned daycare centers
  • To maintain an attendance of 80% during the 8 weeks of the fieldwork
  • Aged 23 to 84 months
  • Being apparently healthy and with no dietary restrictions related to the foods offered with the SOSEP menu.

Exclusion Criteria:

  • Children whose parents of caregivers did not sign a consent form
  • Children who refused to participate in the study
  • Children who refused to adhere to the collections routines.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

Coortes e Intervenções

Grupo / Coorte
Apparently Healthy
Apparently healthy preschool children who attend 3 daycare centers of the Secretariat of Beneficials Works of the First Lady in Guatemalan Western Highlands

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Weight
Prazo: 7th week of observation
Growth, measured trough weight (kg)
7th week of observation
Hemoglobin
Prazo: 8th week of observation
Hemoglobin (mg/dl) measured in Biochemistry Laboratory in La Democracia Hospital, Quetzaltenango, Guatemala.
8th week of observation
Urine Osmolality-1
Prazo: 6th week of observation
Hydration Status= measured in 24-h urine through urine volume and osmolality in osmometer Model Löser 815. Results in mOsm/kg.
6th week of observation
Height
Prazo: 7th week of observation
Growth, measured trough height (cm).
7th week of observation
Urine Osmolality-2
Prazo: 7th week of observation
Hydration Status= measured in 24-h urine through urine volume and osmolality Osmometer Model Löser 815. Results in mOsm/kg.
7th week of observation
Urine Osmolality-3
Prazo: 8th week of observation
Hydration Status= measured in 24-h urine through urine volume and osmolality in two different osmometers (Löser 815 and Osmomat 030). Results in mOsm/kg.
8th week of observation
Urine Urea
Prazo: 8th week of oservation

Urine solutes measured by the Scientific Instrumentation Center from the Granada University, Spain:

urea (mg/l)

8th week of oservation
Urine Uric Acid
Prazo: 8th week of oservation

Urine solutes measured by the Scientific Instrumentation Center from the Granada University, Spain:

uric acid (mg/l)

8th week of oservation
Urine Sodium
Prazo: 8th week of oservation

Urine solutes measured by the Scientific Instrumentation Center from the Granada University, Spain:

sodium (mg/l)

8th week of oservation
Urine Potassium
Prazo: 8th week of oservation

Urine solutes measured by the Scientific Instrumentation Center from the Granada University, Spain:

potassium (mg/l)

8th week of oservation
Urine Calcium
Prazo: 8th week of oservation

Urine solutes measured by the Scientific Instrumentation Center from the Granada University, Spain:

calcium (mg/l)

8th week of oservation
Urine Magnesium
Prazo: 8th week of oservation

Urine solutes measured by the Scientific Instrumentation Center from the Granada University, Spain:

magnesium (mg/l)

8th week of oservation
Urine Phosphorus
Prazo: 8th week of oservation

Urine solutes measured by the Scientific Instrumentation Center from the Granada University, Spain:

inorganic phosphorus (mg/l)

8th week of oservation
Urine 15-f2t-Isoprostanes
Prazo: 8th week of observation

Urine Oxidation biomarkers:

15-f2t-Isoprostanes (ng/mL) Measured at the Institute of Nutrition and Food Technology, Center of Biomedical Research, University of Granada using ELISA assay kit (Oxford Biomedical Research, Inc., Catalog # EA84.102606, Michigan, USA)

8th week of observation
Urine 8-Hydroxydeoxyguanosine
Prazo: 8th week of observation

Urine Oxidation biomarkers:

8-Hydroxydeoxyguanosine (ng/mL) Measured at the Institute of Nutrition and Food Technology, Center of Biomedical Research, University of Granada using ELISA assay kits (JaICA, Nikken SEIL Co., Ltd, Catalog# IM-KOGHS 040914E, Shizouka, Japan).

8th week of observation
Catalase Activity
Prazo: 8th week of observation

Activity of antioxidant enzymes in red blood cells; measured at the Institute of Nutrition and Food Technology, Center of Biomedical Research, University of Granada, using ELISA system:

Catalase Activity (nmol/seg/g Hb)

8th week of observation
Superoxide Dismutase Activity
Prazo: 8th week of observation
Activity of antioxidant enzymes in red blood cells; measured at the Institute of Nutrition and Food Technology, Center of Biomedical Research, University of Granada, using ELISA system Superoxide Dismutase Activity (U/g Hb)
8th week of observation
Gluthathione Reductase
Prazo: 8th week of observation
Activity of antioxidant enzymes in red blood cells; measured at the Institute of Nutrition and Food Technology, Center of Biomedical Research, University of Granada, using ELISA system Gluthathione Reductase Activity (umol/min/g Hb)
8th week of observation
Gluthathione Peroxidase
Prazo: 8th week of observation
Activity of antioxidant enzymes in red blood cells; measured at the Institute of Nutrition and Food Technology, Center of Biomedical Research, University of Granada, using ELISA system Gluthathione Peroxidase Activity (uU/g Hb)
8th week of observation
Retinol
Prazo: 8th week of observation

Content of antioxidant compounds in plasma; Scientific Instrumentation Center, University of Granada.

Retinol (mg/dl)

8th week of observation
Alpha-tocopherol
Prazo: 8th week of observation

Content of antioxidant compounds in plasma; Scientific Instrumentation Center, University of Granada.

Alpha-tocopherol (mg/l)

8th week of observation
Beta-Carotenes
Prazo: 8th week of observation

Content of antioxidant compounds in plasma; Scientific Instrumentation Center, University of Granada.

Beta-carotenes (mg/l)

8th week of observation
Coenzyme Q9
Prazo: 8th week of observation

Content of antioxidant compounds in plasma; Scientific Instrumentation Center, University of Granada.

Coenzyme Q9 (mg/l)

8th week of observation
Coenzyme Q10
Prazo: 8th week of observation

Content of antioxidant compounds in plasma; Scientific Instrumentation Center, University of Granada.

Coenzyme Q10 (mg/l)

8th week of observation
Plasma Interleukin-1B
Prazo: 8th week of observation

Plasma Interleukines; measured at the Institute of Nutrition and Food Technology, Center of Biomedical Research, University of Granada, using the Luminex system:

Plasma IL-1B (pg/ml)

8th week of observation
Plasma Interleukin-6
Prazo: 8th week of observation

Plasma Interleukines; measured at the Institute of Nutrition and Food Technology, Center of Biomedical Research, University of Granada, using the Luminex system:

Plasma IL-6 (pg/ml)

8th week of observation
Plasma Interleukin-8
Prazo: 8th week of observation

Plasma Interleukines; measured at the Institute of Nutrition and Food Technology, Center of Biomedical Research, University of Granada, using the Luminex system:

Plasma IL-8 (pg/ml)

8th week of observation
Plasma Interleukin-10
Prazo: 8th week of observation

Plasma Interleukines; measured at the Institute of Nutrition and Food Technology, Center of Biomedical Research, University of Granada, using the Luminex system:

Plasma IL-10 (pg/ml)

8th week of observation
Plasma Tumor Necrosis Factor-Alpha
Prazo: 8th week of observation

Plasma Interleukines; measured at the Institute of Nutrition and Food Technology, Center of Biomedical Research, University of Granada, using the Luminex system:

Plasma Tumor Necrosis Factor-Alpha (pg/ml)

8th week of observation
Saliva Interleukin-1B
Prazo: 8th week of observation
Saliva Interleukines; measured at the Institute of Nutrition and Food Technology, Center of Biomedical Research, University of Granada, using the Luminex system: Saliva IL-1B (pg/ml)
8th week of observation
Saliva Interleukin-6
Prazo: 8th week of observation
Saliva Interleukines; measured at the Institute of Nutrition and Food Technology, Center of Biomedical Research, University of Granada, using the Luminex system: Saliva IL-6 (pg/ml)
8th week of observation
Saliva Interleukin-8
Prazo: 8th week of observation
Saliva Interleukines; measured at the Institute of Nutrition and Food Technology, Center of Biomedical Research, University of Granada, using the Luminex system: Saliva IL-8 (pg/ml)
8th week of observation
Saliva Interleukin-10
Prazo: 8th week of observation
Saliva Interleukines; measured at the Institute of Nutrition and Food Technology, Center of Biomedical Research, University of Granada, using the Luminex system Saliva IL-10 (pg/ml)
8th week of observation
Saliva Tumor Necrosis Factor-Alpha
Prazo: 8th week of observation

Saliva Interleukines; measured at the Institute of Nutrition and Food Technology, Center of Biomedical Research, University of Granada, using the Luminex system:

Saliva Tumor Necrosis Factor-Alpha (pg/ml)

8th week of observation
Fecal Calprotectin
Prazo: 8th week of observation
Fecal Calprotectin (mg/kg) measured using the ELISA assay kit from Calpro-Lab (Catalog # CAL0100).
8th week of observation
Intestinal Parasitosis
Prazo: 8th week of observation
Intestinal Parasitosis, measured by Biochemistry Laboratory, La Democracia Hospital, Quetzaltenango, Guatemala. Parasite cysts presence in feces.
8th week of observation
Giardiasis Infection Presence-1
Prazo: 7th week of observation
Analyses done by ELISA assay kit (ProSpecT Giardia EZ, catalog #R2458596), absorbance (O.D)
7th week of observation
Giardiasis Infection Presence-2
Prazo: 8th week of observation
Analyses done by ELISA assay kit (ProSpecT Giardia EZ, catalog #R2458596), absorbance (O.D)
8th week of observation
White Urine Cell Count
Prazo: 8th week of observation
White urine cell count (per field), to be determined in Biochemistry Laboratory in La Democracia Hospital, Quetzaltenango Guatemala.
8th week of observation
White Blood Cell Count
Prazo: 8th week of observation
White blood cell count (cells/ul), to be determined in Biochemistry Laboratory in La Democracia Hospital, Quetzaltenango Guatemala.
8th week of observation

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Colaboradores

Investigadores

  • Investigador principal: Maria J. Soto-Méndez, MSc, Center for Studies of Sensory Impairment, Aging and Metabolism

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo

1 de junho de 2012

Conclusão Primária (Real)

1 de novembro de 2012

Conclusão do estudo (Real)

1 de novembro de 2012

Datas de inscrição no estudo

Enviado pela primeira vez

25 de julho de 2014

Enviado pela primeira vez que atendeu aos critérios de CQ

28 de julho de 2014

Primeira postagem (Estimativa)

30 de julho de 2014

Atualizações de registro de estudo

Última Atualização Postada (Estimativa)

30 de julho de 2014

Última atualização enviada que atendeu aos critérios de controle de qualidade

28 de julho de 2014

Última verificação

1 de julho de 2014

Mais Informações

Termos relacionados a este estudo

Termos MeSH relevantes adicionais

Outros números de identificação do estudo

  • CeSSIAM_02

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever